1
Observational Pharmacokinetic Study Of GW679769 In Subjects With Renal Impairment
Condition(s):VomitingLast Updated:August 4, 2017Completed
Casopitant as an Intervention: 32 Clinical Trials, Page 1 of 4
Hide Studies Not Open or Pending
2
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer
Condition(s):Nausea and Vomiting, Chemotherapy-InducedLast Updated:August 4, 2017Completed
3
A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant).
Condition(s):Nausea and Vomiting, Chemotherapy-InducedLast Updated:September 12, 2017Completed
4
A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers
Condition(s):Nausea and Vomiting, Chemotherapy-InducedLast Updated:August 9, 2017Completed
5
A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults
Condition(s):Nausea and Vomiting, Chemotherapy-InducedLast Updated:August 3, 2017Completed
6
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769]
Condition(s):Nausea and Vomiting, Chemotherapy-InducedLast Updated:September 12, 2017Completed
7
Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment
Condition(s):VomitingLast Updated:September 25, 2017Completed
8
Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
Condition(s):Nausea and Vomiting, PostoperativeLast Updated:October 26, 2016Completed
9
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
Condition(s):Nausea and Vomiting, Postoperative; Postoperative Nausea and VomitingLast Updated:March 23, 2017Completed
10
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
Condition(s):Vomiting; Nausea; Nausea and Vomiting, Chemotherapy-InducedLast Updated:September 10, 2012Completed